Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 717 | 219 | 809 | 840 | 838 |
| Accounts receivable | -5,559 | 28,283 | -23,598 | 2,228 | -4,986 |
| Accounts payable and accrued liabilities | -4,117 | N/A | 7,117 | 462 | -6,704 |
| Other Working Capital | -13,254 | 31,964 | -16,042 | -4,248 | -18,491 |
| Other Operating Activity | -9,457 | -50,016 | 16,352 | -27,153 | -17,403 |
| Operating Cash Flow | $-31,670 | $10,450 | $-15,362 | $-27,871 | $-46,746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -347 | N/A | N/A | N/A | -79 |
| Purchase Of Investment | -142,397 | -120,809 | -170,229 | -69,451 | -163,504 |
| Sale Of Investment | 167,766 | 118,207 | 120,432 | 115,111 | 110,566 |
| Other Investing Activity | -162 | -416 | -421 | -39 | 0 |
| Investing Cash Flow | $24,860 | $-3,018 | $-50,218 | $45,621 | $-53,017 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,639 | 688 | 0 | 1,340 | 405 |
| Financing Cash Flow | $1,639 | $688 | $0 | $1,340 | $405 |
| Beginning Cash Position | 94,172 | 86,052 | 151,632 | 132,542 | 231,900 |
| End Cash Position | 89,001 | 94,172 | 86,052 | 151,632 | 132,542 |
| Net Cash Flow | $-5,171 | $8,120 | $-65,580 | $19,090 | $-99,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,670 | 10,450 | -15,362 | -27,871 | -46,746 |
| Capital Expenditure | -509 | N/A | N/A | N/A | -79 |
| Free Cash Flow | -32,179 | 10,450 | -15,362 | -27,871 | -46,825 |